Beyond Bone Density: High Vitamin D Levels Suppress Atherogenic Lipids in Elite Athletes

#1

A cross-sectional registry study of 773 male professional athletes reveals that higher serum 25-hydroxyvitamin D concentrations are independently associated with significantly lower levels of atherogenic lipids, including low-density lipoprotein cholesterol (LDL-C), triglycerides, and the genetically driven cardiovascular risk factor lipoprotein(a). This beneficial relationship remains robust even when controlling for seasonal variation, anthropometric data, and training-related variables.

The historical debate over whether vitamin D acts as a direct metabolic driver or merely serves as a passive biomarker of outdoor activity and general health has long been clouded by lifestyle variables. In heterogeneous general populations, factors like obesity, smoking, physical inactivity, and preexisting chronic illnesses obscure the true relationship between circulating 25-hydroxyvitamin D [25(OH)D] and cardiovascular risk. This study bypasses these confounding barriers by utilizing an optimized human physiological model: 773 elite male professional athletes from German first- and second-division teams. Characterized by high physical fitness, structured training regimens, uniform lifestyle characteristics, and an absence of chronic disease, this cohort isolated the metabolic associations of vitamin D with minimized lifestyle-related noise.

The core finding of this study shifts the focus of vitamin D optimization from basic musculoskeletal protection to advanced cardiometabolic defense. Higher circulating levels of 25(OH)D were linearly linked to a cleaner, more favorable cardiovascular lipid profile. Crucially, the benefit extends beyond traditional lipid fractions into lipoprotein(a) [Lp(a)], a highly atherogenic, genetically determined particle that is notoriously resistant to conventional exercise and dietary modifications.

By analyzing athletes across stratified sufficiency thresholds, the researchers discovered a distinct, graded response: individuals exceeding conventional clinical sufficiency benchmarks exhibited the lowest atherogenic lipid metrics. While the cross-sectional architecture prevents a definitive causal declaration, the preservation of these lipid-lowering associations after intense multivariable adjustments strongly implies that vitamin D signaling participates directly in hepatic lipid homeostasis and vascular protection.

Actionable Insights

For clinical professionals and longevity biohackers aiming to minimize lifelong cardiovascular risk (“cholesterol years”), this study provides concrete targets that challenge standard clinical sufficiency ranges. The traditional threshold of 30 ng/mL for vitamin D sufficiency appears inadequate for optimal lipid metabolism. Stratification data demonstrates that pushing serum 25(OH)D concentrations past 50 ng/mL correlates with a progressively optimized lipid panel.

The quantified real-world magnitude of these benefits, extracted via multivariable linear regression, reveals the specific impact per unit of vitamin D optimization:

  • LDL Cholesterol Reduction : Every 1 ng/mL increase in serum 25(OH)D decreases LDL-C by 0.194 mg/dL.

  • Triglyceride Reduction : Every 1 ng/mL increase in serum 25(OH)D decreases triglycerides by 0.568 mg/dL.

  • Lipoprotein(a) Reduction : Every 1 ng/mL increase in serum 25(OH)D results in a 1.1% relative decrease in log-transformed Lp(a) concentration.

  • Performance Enhancement : Achieving a vitamin D level above 50 ng/mL is associated with a peak aerobic capacity of 4.73 W/kg, compared to just 3.36 W/kg in the insufficient (<30 ng/mL) group.

Practitioners should prioritize consistent biochemical tracking to safely manage these higher targets, recognizing that optimal athletic performance and low atherogenic lipid metrics map tightly to these elevated tiers.

Source:

  • Open Access Paper: Vitamin D Status and Atherogenic Lipid Profiles, Including Lipoprotein(a), in Elite Athletes
  • Institution : Department of Cardiology and Angiology, Justus-Liebig-University Giessen
  • Country : Germany
  • Journal Name : Nutrients
  • Impact Evaluation: The impact score of this journal is 5.9, evaluated against a typical high-end range of 0–60+ for top general science, therefore this is a Medium impact journal.
4 Likes
#2

It says over 50 ng/mL but doesn’t mention a ceiling. I had always understood that there is a “sweet spot” and too high correlated with higher mortality.

#3

100 ng/mL is considered excessive, above 150 is toxic

1 Like
#4

People should be really careful, and not just because what obtains for elite athletes might not obtain for your average longevity enthusiast from at least two perspectives (1 - different effect in nonelite athletes; 2 - questionable if elite level of exercise is optimal for longevity). People should be careful, because taking in higher levels of supplemental vitamin D can end up with calcified aortic valve leaflets in as little as six months - a very bad outcome - and vascular calcification in general. If you have a tendency to other vascular or renal conditions it might get even worse. Vitamin D needs more careful dosing consideration than “more is better” - it’s a more goldilocks levels type hormone. And hopefully people are also careful with calcium supplementation.

Aortic Stiffness and Vitamin D are Independent Markers of Aortic Calcification in Patients with Peripheral Arterial Disease and in Healthy Subjects

https://www.sciencedirect.com/science/article/pii/S1078588411005107

Supplemental calcium and vitamin D and long-term mortality in aortic stenosis

https://heart.bmj.com/content/108/12/964

2 Likes
#5

This only applies to peripheral arterial disease patients though.

In PAD patients, vit D levels were positively correlated with aortic calcification. Higher vitamin D within this deficient cohort was tied to more calcification. In healthy controls, vit D levels were negatively correlated with aortic calcification. Lower vitamin D meant higher calcification.

This is in patients with aortal stenosis.

I’m pointing this out because the above seems to imply that all patients taking higher vitamin D can end up with calcified aortic valve issues when this only applies to patients with sole kind of cvd.

2 Likes
#6

As I said, other vascular and renal issues can be a significant factor. The problem is that you may have nonsymptomatic vulnerabilites you may not even be aware of (and which may longer term lead to atherosclerosis, PAD, CKD etc.), and therefore for you excessive supplementation with vit. D, calcium, phosphorus etc. can be far more dangerous than for someone without these vulnerabilities. In that scenario, I see supraphysiological supplementation of these molecules as an unnecessary risk for no particular gain.

By the by, studies such as those in these athletes must be approached cautiously wrt. confounders. I can see a difference in for example higher levels of circulating D3 which are a result of sun exposure (in extensively outdoor exercising athletes), and that being different from someone who is not an athlete but supplements with D3. How you get there might make a difference.

1 Like
#7

A task I should do is to take my 4 years of weekly blood tests and run correlation calculations. I currently taking 25ohd from about 120 nmol (48) to 250 (100). I may also try a bit above 250. I did get to 400 in the past.

1 Like